MOORESTOWN, N.J., April 23, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare Corporation® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, and Strategic Solutions Network, a privately-held business-to-business conference company, will present a free webinar entitled Important Medication Safety Considerations for COVID-19 Treatment on Thursday, May 7, 2020 at 1 p.m. EDT. Participants may register here. The webinar will discuss the importance of understanding the risks associated with COVID-19 treatment risks, particularly with vulnerable individuals who have several chronic diseases and take multiple medications.
“There is an unprecedented interest in medications that may have potential to treat COVID-19,” states TRHC Chairman and CEO Calvin H. Knowlton, PhD. “In this webinar, our Precision Pharmacotherapy Research & Development Institute will share the research it has completed to-date on the safety of these medications, focusing on some of the nation’s most vulnerable populations. THRC is laser-focused on supporting pharmacists and other providers with the tools needed to assure medication safety during this pandemic.”
Featured webinar speakers include: TRHC Chief Medical Officer Richard O. Schamp, MD, TRHC Chief Scientific Officer Jacques Turgeon, BPharm, PhD, and TRHC Precision Pharmacotherapy Research & Development Institute Chief Operating Officer Veronique Michaud, BPharm, PhD.
The presentation will identify the most widely discussed treatment options for COVID-19, the risk of drug-drug interactions and potential for major side effects. Additionally, the webinar will cover the relevant history and progression of COVID-19 and feature how simulations will become a good tool for COVID-19 medication management.
To participate in the webinar, please register here. This webinar is relevant for Individuals associated with health plans, Medicare Advantage plans, PACE, hospitals, health systems, ACOs, providers, and healthcare/health plan consultants.
To interview one of the webinar’s presenters, please contact Amanda Bednar, Director of Corporate Communication at abednar@trhc.com or 856-912-5714.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize performance to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.
About Strategic Solutions Network
Strategic Solutions Network (SSN) is a privately-held business-to-business conference company based in Boca Raton, FL and New York. SSN was founded in 2009. The SSN Team comprises individuals who have deep event industry experience and proven talent in delivering value-laden information to business leaders. Every team member comes with multi-year conference industry experience and most team members enjoy long service with SSN.
Forward-Looking Statement
This press release includes forward-looking statements that we believe to be reasonable as of today’s date. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. These forward-looking statements include, among other things, our goals and expectations regarding the combined company and the integration of PW into TRHC, the expected synergies from the combined company and the expected financial and operating performance of TRHC following the completion of the acquisition. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the risk that we may not be able to achieve our expectations for the combined companies due to challenges in integration and inability to retain key employees; fluctuations in our financial results; the acceptance and use of our products and services by PACE organizations and pharmacies; the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; our ability to maintain relationships with a specified drug wholesaler; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; the requirements of being a public company; our ability to recognize the expected benefits from acquisitions on a timely basis or at all; and the other risk factors set forth from time to time in our filings with the Securities and Exchange Commission (“SEC”), including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 1, 2019, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website ir.trhc.com or upon request from our Investor Relations Department. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.
Media Contact
Amanda Bednar
abednar@trhc.com
T: (856) 912-5714
Dianne Semingson
dsemingson@trhc.com
T: (215) 870-0829
Investors
Frank Sparacino
fsparacino@trhc.com
T: (312) 451-2157